Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 3, p. 212, doi. 10.1038/cgt.2011.83
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2012 AND VI 19 AND IP 3
Results: 8
1
2
Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 3, p. 171, doi. 10.1038/cgt.2011.73
- By:
- Publication type:
- Article
3
Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 3, p. 181, doi. 10.1038/cgt.2011.75
- By:
- Publication type:
- Article
4
Targeting 14-3-3zeta in cancer therapy.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 3, p. 153, doi. 10.1038/cgt.2011.85
- By:
- Publication type:
- Article
5
Oncolytic Herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 3, p. 160, doi. 10.1038/cgt.2011.70
- By:
- Publication type:
- Article
6
Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 3, p. 202, doi. 10.1038/cgt.2011.82
- By:
- Publication type:
- Article
7
Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 3, p. 218, doi. 10.1038/cgt.2011.86
- By:
- Publication type:
- Article
8
Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 3, p. 192, doi. 10.1038/cgt.2011.77
- By:
- Publication type:
- Article